CG, who is 9-months post MI and insists that he is compliant with his antiplatelet therapy, presents with STEMI. What should be considered when treating a STEMI patient on chronic clopidogrel therapy? Medscape Cardiology
AASK investigators are unsure why progression of kidney disease went unabated despite achieving blood-pressure targets of 0.22, were protected. Heartwire
True secondary hypertension represents only about 5% of patients -- in his video blog Dr. Black presents detailed criteria for how clinicians can efficiently assess its possible causes. Medscape Cardiology
Functional polymorphism increases T-cell activation and disease severity and reduces clinical effectiveness of intravenous 344immunoglobulins. Medscape Medical News
New research shows that a history of hypertension increases the risk for mild cognitive impairment, suggesting that prevention and management of hypertension may lower the risk for cognitive decline. Medscape Medical News
Early research suggests the potential anticancer therapeutics might be especially risky for patients with prior or ongoing heart disease. Medscape Medical News
